Organisation and Summary of Significant Accounting Policies - Additional Information (Details)	1 Months Ended	12 Months Ended
	Feb. 28, 2021 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)	Jun. 30, 2022 $ / shares	Mar. 31, 2022 USD ($)	Jan. 01, 2022 USD ($)	Dec. 31, 2020 USD ($)
Summary of Significant Accounting Policies [Line Items]
Cash Cash Equivalents And Marketable Securities		$ 44,400,000
Gross Proceeds from issuance of private placement		16,700,000
Retained Earnings (Accumulated Deficit)		(133,427,000)	$ (94,151,000)
Unrecorded tax benefits			319,000				$ 139,000
Unrecognized tax benefits, accrued interest or penalties		$ 0
Number of operating segments | Segment		1
Issuance of common stock, net of issuance costs			90,506,000
Common stock, conversion basis		1.8249-for-1
Others Income		$ 1,285,000	394,000
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]						Liabilities, Current
Lease liability recognized						$ 800,000
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]					Assets, Current	Assets, Current
Right-of-use asset recognized					$ 700,000	$ 800,000
NIH Grant Income
Summary of Significant Accounting Policies [Line Items]
Others Income		$ 1,000,000.0
Minimum [Member] | Furniture and Fixtures [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful life		5 years
Maximum [Member] | Furniture and Fixtures [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful life		7 years
Corporate Debt Securities [Member] | Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Debt securities, available for sale, maturity period		90 days
Australia R&D credit [Member]
Summary of Significant Accounting Policies [Line Items]
Research and development incentive tax credit refund received			$ 1,300,000
Audit period			4 years
Nasdaq
Summary of Significant Accounting Policies [Line Items]
Ordinary share, bid price | $ / shares				$ 1.00
IPO [Member]
Summary of Significant Accounting Policies [Line Items]
Issuance of common stock, net of issuance costs, shares | shares	6,250,000
Shares issued price per share | $ / shares	$ 16.00
Issuance of common stock, net of issuance costs	$ 90,500,000
Conversion of preferred stock to common stock upon closing of the initial public offering, issued, shares | shares	20,549,478
Deferred Offering Costs		$ 25,000					$ 1,400,000